Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral SclerosisRecruiting
NCT07257302NAUpdated Jul 30, 2026
Sponsor: National Center of Neurology and Psychiatry, Japan
Amyotrophic Lateral Sclerosis (ALS)
Japan
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 StudyActive Not Recruiting
NCT06534892Phase 3Updated Jul 29, 2026
Sponsor: GlaxoSmithKline
Respiratory Syncytial Virus Infections
United States, Australia, Belgium, Canada, Estonia +12 more
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)Recruiting
NCT06274801Phase 3Updated Jul 29, 2026
Sponsor: Gossamer Bio USA, Inc.
Pulmonary Arterial Hypertension
United States, Argentina, Australia, Belgium, Brazil +25 more
Study of DSP-0390 in Patients With Recurrent High-Grade GliomaActive Not Recruiting
NCT05023551EARLY_Phase 1Updated Jul 29, 2026
Sponsor: Sumitomo Pharma America, Inc.
High Grade Glioma · Glioblastoma Multiforme
United States, Japan
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsRecruiting
NCT06427941Phase 1Updated Jul 29, 2026
Sponsor: BeOne Medicines
Metastatic Hepatocellular Carcinoma · Local Advanced Hepatocellular Carcinoma · Alpha-fetoprotein (AFP)-Producing Gastric Cancer · Extragonadal Yolk Sac Tumors
United States, Brazil, China, France, Italy +4 more
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerRecruiting
NCT07525206Phase 3Updated Jul 29, 2026
Sponsor: AbbVie
Colorectal Cancer
United States, Belgium, Greece, Japan, Portugal +3 more
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety TrialRecruiting
NCT05334368Phase 3Updated Jul 29, 2026
Sponsor: GlaxoSmithKline
Hypereosinophilic Syndrome
United States, Argentina, Australia, Belgium, Brazil +16 more
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR MutationsCompleted
NCT05258279Phase 2Updated Jul 29, 2026
Sponsor: Juntendo University
Non-squamous Non-small-cell Lung Cancer · EGFR Activating Mutation
Japan
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)Recruiting
NCT07044336Phase 3Updated Jul 29, 2026
Sponsor: AstraZeneca
Endometrial Cancer · Malignant Solid Tumour
United States, Argentina, Australia, Austria, Belgium +23 more
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsRecruiting
NCT05156398Phase 3Updated Jul 29, 2026
Sponsor: Pfizer
Migraine
United States, Canada, France, Italy, Japan +2 more
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)Recruiting
NCT07100080Phase 2, Phase 3Updated Jul 29, 2026
Sponsor: Bristol-Myers Squibb
Non-Small Cell Lung Cancer
United States, Argentina, Belgium, Canada, Chile +20 more
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple MyelomaActive Not Recruiting
NCT06413498Phase 3Updated Jul 29, 2026
Sponsor: Kite, A Gilead Company
Multiple Myeloma
United States, Australia, Austria, Belgium, Canada +10 more
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]Active Not Recruiting
NCT02486718Phase 3Updated Jul 29, 2026
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Australia, Belgium, China, France +16 more
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1Active Not Recruiting
NCT05680818Phase 3Updated Jul 29, 2026
Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company
Autosomal Dominant Hypocalcemia (ADH)
United States, Australia, Canada, Czechia, Denmark +5 more
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaRecruiting
NCT03460977Phase 1Updated Jul 29, 2026
Sponsor: Pfizer
Metastatic Castration Resistant Prostate Cancer (mCRPC) · Small Cell Lung Cancer (SCLC) · Follicular Lymphoma (FL)
United States, Bulgaria, China, Japan, Poland +3 more
EMBRACE Tremor BiFUSRecruiting
NCT06974916NAUpdated Jul 29, 2026
Sponsor: InSightec
Essential Tremor
Finland, Germany, Italy, Japan, Spain +2 more
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsActive Not Recruiting
NCT06120491Phase 3Updated Jul 29, 2026
Sponsor: AstraZeneca
Metastatic Castration-Sensitive Prostate Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.Recruiting
NCT07732738NAUpdated Jul 29, 2026
Sponsor: China-Japan Friendship Hospital
Obesity
China
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2Recruiting
NCT06219941Phase 2Updated Jul 29, 2026
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Cancer · Biliary Tract Cancer · Pancreatic Ductal Adenocarcinoma
United States, Australia, Canada, China, Georgia +9 more
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)Active Not Recruiting
NCT06486441Phase 3Updated Jul 29, 2026
Sponsor: Gilead Sciences
Endometrial Cancer
United States, Australia, Brazil, Canada, China +14 more
A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin LymphomaTerminated
NCT06622226Phase 1Updated Jul 29, 2026
Sponsor: Ono Pharmaceutical Co., Ltd.
Non Hodgkin Lymphoma
Japan
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus ErythematosusActive Not Recruiting
NCT06015737Phase 3Updated Jul 29, 2026
Sponsor: AstraZeneca
Cutaneous Lupus Erythematosus
United States, Argentina, Australia, Austria, Brazil +27 more
A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)Completed
NCT04458831N/AUpdated Jul 29, 2026
Sponsor: Sanofi
Plasma Cell Myeloma
United States, Argentina, Austria, Belgium, China +16 more
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)Completed
NCT05996835Phase 2Updated Jul 29, 2026
Sponsor: Novartis Pharmaceuticals
Acute Kidney Injury Due to Sepsis
United States, Argentina, Australia, Austria, Belgium +12 more
Pan Tumor Rollover StudyRecruiting
NCT03899155Phase 2Updated Jul 29, 2026
Sponsor: Bristol-Myers Squibb
Cancer
United States, Argentina, Australia, Austria, Belgium +33 more

Previous page Next page